Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated Diabetics

Introduction: Intermittent flash glucose monitoring (FGM) and real-time continuous glucose monitoring (CGM) are used to monitor glycemic excursions for 14 days and can demonstrate time in range (TIR), time above range (TAR), and time below range (TBR). The utility of CGM metrics, such as TIR, TBR, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Toshiyuki Horiuchi, Junichiro Adachi, Yoshihiro Sekiguchi, Akiko Kanamaru
Format: Article
Language:English
Published: Knowledge E 2021-10-01
Series:Dubai Diabetes and Endocrinology Journal
Subjects:
Online Access:https://www.karger.com/Article/FullText/519438
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850034587208515584
author Toshiyuki Horiuchi
Junichiro Adachi
Yoshihiro Sekiguchi
Akiko Kanamaru
author_facet Toshiyuki Horiuchi
Junichiro Adachi
Yoshihiro Sekiguchi
Akiko Kanamaru
author_sort Toshiyuki Horiuchi
collection DOAJ
description Introduction: Intermittent flash glucose monitoring (FGM) and real-time continuous glucose monitoring (CGM) are used to monitor glycemic excursions for 14 days and can demonstrate time in range (TIR), time above range (TAR), and time below range (TBR). The utility of CGM metrics, such as TIR, TBR, and TAR, in diabetics treated with insulin combined with antihyperglycemic drugs is uncertain. Methods: In a cross-sectional and retrospective study, we investigated the relationship between target metrics from CGM/FGM and HbA1c or glucose variabilities in 80 type 1 and 2 diabetic patients receiving insulin treatment with ≥1 injections per day. The proportions of TIR, TAR, and TBR from FGM in relation to HbA1c and coefficient of variation (CV)% in types 1 and 2 diabetics were analyzed. Multivariable analyses were performed regarding the associations of TIR with biochemical factors and glycemic variabilities. TBR was also examined in relation to antidiabetic agents and diabetic type in multiple regression analyses. Finally, the association of retinopathy with FGM-CGM metrics was examined using a logistic analysis. Results: When patients were grouped by sex and diabetic type, significant differences in age, TIR, TBR, high-density lipoprotein cholesterol (HDLC), and insulin dose were detected using Kruskal-Wallis analyses. HbA1c significantly correlated with TIR (p < 0.001) and TAR (p < 0.001) using Pearson’s correlation analysis. TBR significantly correlated with CV% (p < 0.001). Multivariable analysis of TIR showed a significant negative association with HbA1c (p = 0.02). Incretin combined with insulin therapy reduced the TBR proportion significantly according to the multivariate analysis. Retinopathy tended to be related to HbA1c (p = 0.059) and duration (p = 0.078) but not TIR (p = 0.891), according to the logistic analysis. Conclusions: These results demonstrate that CGM metrics reflect glucose control for 2 weeks using TIR. In addition, combined therapy with incretin and insulin therapy is superior for reducing hypoglycemia, based on TBR. Thus, TBR is also useful for monitoring hypoglycemia. However, FGM/CGM metrics do not predict retinopathy accurately.
format Article
id doaj-art-d60cc3f139ed459391e8abc85880ee3b
institution DOAJ
issn 2673-1797
2673-1738
language English
publishDate 2021-10-01
publisher Knowledge E
record_format Article
series Dubai Diabetes and Endocrinology Journal
spelling doaj-art-d60cc3f139ed459391e8abc85880ee3b2025-08-20T02:57:46ZengKnowledge EDubai Diabetes and Endocrinology Journal2673-17972673-17382021-10-011610.1159/000519438519438Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated DiabeticsToshiyuki Horiuchi0Junichiro Adachi1Yoshihiro Sekiguchi2Akiko Kanamaru3Department of Medicine and Endocrinology Kyoujokai Clinic and Tokyo Metropolitan Health and Medical Toshima Hospital, Tokyo, JapanDepartment of Endocrinology and Metabolism, Ome Municipal Hospital, Ome, JapanDepartment of Endocrinology and Metabolism, Ome Municipal Hospital, Ome, JapanDepartment of Rehabilitation, Tokyo Metropolitan Geriatric Hospital, Tokyo, JapanIntroduction: Intermittent flash glucose monitoring (FGM) and real-time continuous glucose monitoring (CGM) are used to monitor glycemic excursions for 14 days and can demonstrate time in range (TIR), time above range (TAR), and time below range (TBR). The utility of CGM metrics, such as TIR, TBR, and TAR, in diabetics treated with insulin combined with antihyperglycemic drugs is uncertain. Methods: In a cross-sectional and retrospective study, we investigated the relationship between target metrics from CGM/FGM and HbA1c or glucose variabilities in 80 type 1 and 2 diabetic patients receiving insulin treatment with ≥1 injections per day. The proportions of TIR, TAR, and TBR from FGM in relation to HbA1c and coefficient of variation (CV)% in types 1 and 2 diabetics were analyzed. Multivariable analyses were performed regarding the associations of TIR with biochemical factors and glycemic variabilities. TBR was also examined in relation to antidiabetic agents and diabetic type in multiple regression analyses. Finally, the association of retinopathy with FGM-CGM metrics was examined using a logistic analysis. Results: When patients were grouped by sex and diabetic type, significant differences in age, TIR, TBR, high-density lipoprotein cholesterol (HDLC), and insulin dose were detected using Kruskal-Wallis analyses. HbA1c significantly correlated with TIR (p < 0.001) and TAR (p < 0.001) using Pearson’s correlation analysis. TBR significantly correlated with CV% (p < 0.001). Multivariable analysis of TIR showed a significant negative association with HbA1c (p = 0.02). Incretin combined with insulin therapy reduced the TBR proportion significantly according to the multivariate analysis. Retinopathy tended to be related to HbA1c (p = 0.059) and duration (p = 0.078) but not TIR (p = 0.891), according to the logistic analysis. Conclusions: These results demonstrate that CGM metrics reflect glucose control for 2 weeks using TIR. In addition, combined therapy with incretin and insulin therapy is superior for reducing hypoglycemia, based on TBR. Thus, TBR is also useful for monitoring hypoglycemia. However, FGM/CGM metrics do not predict retinopathy accurately.https://www.karger.com/Article/FullText/519438fgmcgm metricsincretinhypoglycemia
spellingShingle Toshiyuki Horiuchi
Junichiro Adachi
Yoshihiro Sekiguchi
Akiko Kanamaru
Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated Diabetics
Dubai Diabetes and Endocrinology Journal
fgm
cgm metrics
incretin
hypoglycemia
title Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated Diabetics
title_full Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated Diabetics
title_fullStr Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated Diabetics
title_full_unstemmed Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated Diabetics
title_short Evaluation of the Association of CGM Metrics with Antihyperglycemic Drugs in Insulin-Treated Diabetics
title_sort evaluation of the association of cgm metrics with antihyperglycemic drugs in insulin treated diabetics
topic fgm
cgm metrics
incretin
hypoglycemia
url https://www.karger.com/Article/FullText/519438
work_keys_str_mv AT toshiyukihoriuchi evaluationoftheassociationofcgmmetricswithantihyperglycemicdrugsininsulintreateddiabetics
AT junichiroadachi evaluationoftheassociationofcgmmetricswithantihyperglycemicdrugsininsulintreateddiabetics
AT yoshihirosekiguchi evaluationoftheassociationofcgmmetricswithantihyperglycemicdrugsininsulintreateddiabetics
AT akikokanamaru evaluationoftheassociationofcgmmetricswithantihyperglycemicdrugsininsulintreateddiabetics